Bio Green Med Solution (BGMS) Exchange Rate Effect (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Exchange Rate Effect of $8000.0 for Q1 2026, up 109.3% year-over-year from $3822.2 in Q1 2025, and up 119.51% quarter-over-quarter from -$41000.0 in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Exchange Rate Effect for 17 consecutive years, with $8000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Exchange Rate Effect rose 109.3% year-over-year to $8000.0; the TTM figure through Mar 2026 stood at -$32000.0 (up 77.3% YoY), while the FY2025 annual figure was -$126000.0, down 72.6% from the prior year.
- Exchange Rate Effect grew to $8000.0 in Q1 2026 per BGMS's latest filing, from -$41000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $345000.0 in Q4 2023 and bottomed at -$234000.0 in Q4 2022.
- Historically, Exchange Rate Effect has averaged -$16625.0 across 5 years, with a median of -$10500.0 in 2024.
- Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 5950.0% — and 2023, when it jumped 247.44%.
- Bio Green Med Solution's Exchange Rate Effect stood at -$234000.0 in 2022, then surged by 247.44% to $345000.0 in 2023, then slumped by 129.57% to -$102000.0 in 2024, then surged by 59.8% to -$41000.0 in 2025, then jumped by 119.51% to $8000.0 in 2026.
- Business Quant data shows BGMS's Exchange Rate Effect at $8000.0 in Q1 2026, -$41000.0 in Q4 2025, and $1000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 138.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -287,000.00 |
| 10 | Bio Green Med Solution | 5.21 Mn | 1.42 Mn | 79,000.00 | 30,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | -41,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | -86,000.00 |
| Dec 31, 2024 | -102,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Mar 31, 2024 | -18,000.00 |
| Dec 31, 2023 | 345,000.00 |
| Sep 30, 2023 | -134,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Dec 31, 2022 | -234,000.00 |
| Sep 30, 2022 | 65,000.00 |
| Jun 30, 2022 | -118,000.00 |
| Mar 31, 2022 | -91,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | -105,000.00 |
| Jun 30, 2021 | 66,000.00 |